Stryker stock falls as Canaccord cuts its target to USD 385
📉 Stryker Corp. stock fell 1.63% to USD 280.13 after Canaccord Genuity cut its price target from USD 400 to USD 385.
⚠️ The analyst downgrade was explicitly attributed to manufacturing problems affecting the medical technology group's operations.
📊 Stryker reported quarterly EPS of USD 3.69 on July 30, 2026, which beat the consensus estimate of USD 3.49 by USD 0.20.
🔮 The company maintains FY 2026 guidance with expected EPS ranging from USD 14.95 to USD 15.10.
💰 Stryker declared a quarterly dividend of USD 0.88 per share with an ex-dividend date of September 30, 2026.
📈 MarketBeat consensus data shows an average price target of USD 378.75, implying roughly 34% upside from the last close.
Bullish Signals
- Stryker Corp. beat quarterly earnings expectations with reported EPS of USD 3.69 versus a consensus estimate of USD 3.49.
- The company maintains robust fiscal year 2026 guidance, projecting EPS between USD 14.95 and USD 15.10.
Risk Factors
- Canaccord Genuity lowered its price target from USD 400 to USD 385 due to cited manufacturing problems.
- The stock closed down 1.63% on September 17, 2026, reflecting fresh pressure from the analyst downgrade and weaker sentiment.
Full Analysis
Stryker Corp. shares declined by 1.63% to close at USD 280.13 on September 17, 2026, following a downgrade from analyst firm Canaccord Genuity. The firm lowered its price target for the medical device manufacturer from USD 400 to USD 385, citing ongoing manufacturing problems as the primary driver for the negative sentiment surrounding the stock.
Despite the analyst cut, Canaccord maintained a Buy rating on Stryker Corp. Recent quarterly earnings reported on July 30, 2026, showed the company beat consensus estimates with EPS of USD 3.69 compared to an expected USD 3.49. The company continues to provide forward guidance for fiscal year 2026, projecting EPS between USD 14.95 and USD 15.10.
MarketBeat data indicates a consensus average price target of USD 378.75, suggesting potential upside from the current trading levels. Stryker Corp. also declared a quarterly dividend of USD 0.88 per share with an ex-dividend date set for September 30, 2026, adding to its shareholder return profile despite the recent price weakness.
